With safety and efficacy profiles aligning with its brand-name formulation, this new patch could be key for women struggling with hormone therapy adherence.
|Articles|January 21, 2008
Two online pharmacies get in trouble with the law
To settle a suit filed by New Jersey authorities, two online pharmacies must pay a fee and stop dispensing drugs to state residents
Advertisement
The online pharmacy Medications4Less and its Canadian partner Ultra Care Pharmacy will have to pay $115,000 to settle a lawsuit that the New Jersey Attorney General's Office and the Division of Consumer Affairs had filed against them. The state authorities charged that the two pharmacies had dispensed medications ordered by a fake doctor and one whose license has been suspended and imported drugs in violation of Food & Drug Administration regulations. As part of their settlement, the defendants must also stop filling prescriptions for state residents.
Advertisement
Related to this article
Investigators link oversight with eroding trust in health authorities and call on future pandemic inquiries to weigh trade-offs.
Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.
Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026
2
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
3
Harms of Public Health Measures Overlooked in COVID-19 Policy Reviews
4
Trutakna Reduces Proteinuria in Adults With Primary IgAN
5